Clinical Trial Update: Immuno-Virological Efficacy of Combination With Trizivir +Tenofovir in Multiresistant HIV Patients [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the immunovirological efficacy of combining Trizivir with Tenofovir in multiresistant HIV patients; the study has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Tenofovir (Tenofovir)
• Trizivir

Snippet

Sponsor: Germans Trias i Pujol Hospital | Conditions: HIV Infections | Phase 4 | Status: TERMINATED